News
-
New Nectr Nootropic Energy Pouches, Powered by Cognizin®, Offer a Novel Way to Stay Alert and Focused
Nectr Energy recently launched their Nectr Nootropics mouth pouches featuring Cognizin® Citicoline. Focused on the energy pouch sector, the brand decided to introduce this innovative delivery system coupled with a key ingredient that was backed by research.
-
Well Traveled Releases a Novel Travel Supplement Featuring IMMUSE™
Kyowa Hakko’s IMMUSE™, a research-backed postbiotic, provides immune support for travelers in this new innovative formula, “Well Traveled Immune Activator.
-
New Doctor-Formulated Energy Supplement Electrolyte Boost, Powered by Cognizin®, Boost Without Water Debuts
Kyowa Hakko’s Cognizin®, a research-backed nootropic, provides brain health support in this new First-of-its-Kind formula, delivered in a simple single-serve sachet
-
Kyowa Hakko USA Celebrates Launch of CENTR Enhanced Functional Sparkling Water featuring Cognizin® Citicoline
Kyowa Hakko USA is excited to announce the launch of CENTR Enhanced sparkling water, a functional beverage with a blend of nootropic and adaptogenic ingredients that includes its Cognizin® citicoline.
-
Kyowa Hakko Announces Glaxon’s Limited-Time Offer Becomes A Permanent Feature
After a resoundingly successful limited-time offering, Glaxon™ has now added Kyowa Hakko’s IMMUSE™ to all SuperGreens Immune formulas. Glaxon™, producer of sports nutrition dietary supplements, launched this summer a SuperGreens Enhanced Immune Edition that, in addition to the power of Glaxon™'s trademarked Supershrooms® Organic Mushroom Blend, included IMMUSE™, a postbiotic that provides immune support at a cellular level - both of which support the immune systems of its customers.
-
Cognizin® Citicoline Launches “Tap Challenge” In the App Store
The Tap Challenge App is finally here for professional button mashers or anyone who wants to challenge themselves each day!
-
Manufacturing strain of Kyowa Hakko Bio’s 2'-fucosyllactose, a human milk oligosaccharide (HMO), passed safety evaluation in China
KYOWA HAKKO BIO CO., LTD. (Kyowa Hakko Bio) is pleased to announce that its manufacturing strain used for producing 2'-fucosyllactose (2’-FL), the most abundant HMO in human milk, has passed the safety evaluation by the Chinese Ministry of Agriculture and Rural Affairs (MARA), while other manufacturing strains used for producing 3'-sialyllactose (3'-SL) and 6'-sialyllactose (6'-SL) are currently under review.
-
Dr. Eri Nakazaki of the Kirin Central Research Institute Wins JSBBA Award for Her Work Developing a Health Food Ingredient to Support Memory
One of Kyowa Hakko’s own is honored for the enhancement of citicoline, which helps healthy elderly adults improve memory function
-
Kyowa Hakko USA Announces the Appointment of Dr. Colin Hill to the Scientific Advisory Board of Award-Winning Postbiotic IMMUSE™
With an impressive background in mining the microbiome for novel therapies, Prof. Hill helped with the definition of a postbiotic as a part of ISAPP.
-
Kyowa Hakko USA Announces the Appointment of Dr. Heather Moday as an Educational Partner for IMMUSE™ LC-Plasma
With a special interest in immune system dysfunction, including autoimmunity, allergy, and the stress-immune connection, Dr. Moday puts IMMUSE™, an award-winning postbiotic, at the forefront of ingredients to look out for in nutritional supplements.